The overall goal of this project is to resolve the molecular mechanism of excitation-contraction-relaxation coupling in normal and diseased skeletal muscles. The whole reaction cycle of E-C-R coupling could be described by three major events occurring in the following sequence: (I) the voltage-dependent interaction between the dihydropyridine receptor (DHPR) and the junctional foot protein (JFP); (II) conformational changes in the JFP to open the SR Ca2+ channel; and (III) release inactivation/recovery processes involving several putative reaction intermediates and modulators. Each of these major events will be investigated utilizing the in vitro E-C coupling assay system (triad) or purified proteins for studying the problems at the molecular level.
In Aim 1 the detailed modes of protein-protein interactions in the signal transmission from the DHPR to the JFP will be resolved. A series of peptides derived from the II-III cytoplasmic loop of the DHPR alpha1 subunit will be screened for the ability to trigger and SR Ca2+ release (Activator) and to block (Blocker) the actions of Activator peptides in the in vitro E-C coupling assay system and peptide binding assays. Appropriate peptides will be used to localize the signal-receiving site(s) in the JFP.
The second aim will explore changes in JFP conformation involved in activation and inactivation of SR Ca2+ release. This will involve investigations of the correlations between the depolarization signal and JFP conformational change, and between the binding of Activator peptide, JFP conformational change and SR Ca2+ release, and of the temporal relation between JFP conformational change and channel opening. The exact location of the site of attachment of conformational probes in the JFP will be investigated to characterize the actual structural changes involved. Local changes and global changes in JFP structure will be monitored by fluorescent reporter groups and circular dichroism, respectively.
The third aim will attempt to elucidate the complete reaction cycle of E-C-R coupling. Efforts will be made to resolve individual reaction intermediates by analyzing five parameters in a parallel. These include: (i) JFP conformational changes; (ii) Ca2+ release rate; (iii) response to a second activation stimulus; (iv) Ca2+ in the SR lumen; and (v) Ca2+ re-uptake rate.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR016922-27
Application #
6171436
Study Section
Physiology Study Section (PHY)
Program Officer
Lymn, Richard W
Project Start
1976-06-01
Project End
2002-03-31
Budget Start
2000-09-01
Budget End
2002-03-31
Support Year
27
Fiscal Year
2000
Total Cost
$506,290
Indirect Cost
Name
Boston Biomedical Research Institute
Department
Type
DUNS #
058893371
City
Watertown
State
MA
Country
United States
Zip Code
02472
Gangopadhyay, Jaya P; Ikemoto, Noriaki (2008) Interaction of the Lys(3614)-Asn(3643) calmodulin-binding domain with the Cys(4114)-Asn(4142) region of the type 1 ryanodine receptor is involved in the mechanism of Ca2+/agonist-induced channel activation. Biochem J 411:415-23
Laver, Derek R; Hamada, Tomoyo; Fessenden, James D et al. (2007) The ryanodine receptor pore blocker neomycin also inhibits channel activity via a previously undescribed high-affinity Ca(2+) binding site. J Membr Biol 220:11-20
Bannister, Mark L; Hamada, Tomoyo; Murayama, Takashi et al. (2007) Malignant hyperthermia mutation sites in the Leu2442-Pro2477 (DP4) region of RyR1 (ryanodine receptor 1) are clustered in a structurally and functionally definable area. Biochem J 401:333-9
Hamada, Tomoyo; Bannister, Mark L; Ikemoto, Noriaki (2007) Peptide probe study of the role of interaction between the cytoplasmic and transmembrane domains of the ryanodine receptor in the channel regulation mechanism. Biochemistry 46:4272-9
Murayama, Takashi; Oba, Toshiharu; Hara, Hiroshi et al. (2007) Postulated role of interdomain interaction between regions 1 and 2 within type 1 ryanodine receptor in the pathogenesis of porcine malignant hyperthermia. Biochem J 402:349-57
Gangopadhyay, Jaya Pal; Ikemoto, Noriaki (2006) Role of the Met3534-Ala4271 region of the ryanodine receptor in the regulation of Ca2+ release induced by calmodulin binding domain peptide. Biophys J 90:2015-26
Bannister, Mark L; Ikemoto, Noriaki (2006) Effects of peptide C corresponding to the Glu724-Pro760 region of the II-III loop of the DHP (dihydropyridine) receptor alpha1 subunit on the domain- switch-mediated activation of RyR1 (ryanodine receptor 1) Ca2+ channels. Biochem J 394:145-52
Yang, Zhaokang; Ikemoto, Noriaki; Lamb, Graham D et al. (2006) The RyR2 central domain peptide DPc10 lowers the threshold for spontaneous Ca2+ release in permeabilized cardiomyocytes. Cardiovasc Res 70:475-85
Kobayashi, Shigeki; Bannister, Mark L; Gangopadhyay, Jaya P et al. (2005) Dantrolene stabilizes domain interactions within the ryanodine receptor. J Biol Chem 280:6580-7
Murayama, Takashi; Oba, Toshiharu; Kobayashi, Shigeki et al. (2005) Postulated role of interdomain interactions within the type 1 ryanodine receptor in the low gain of Ca2+-induced Ca2+ release activity of mammalian skeletal muscle sarcoplasmic reticulum. Am J Physiol Cell Physiol 288:C1222-30

Showing the most recent 10 out of 50 publications